bioAffinity Technologies, Inc. (BIAF)

bioAffinity Technologies, Inc. (BIAF) is a Diagnostics & Research company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $4.8M; returns 1 day -11.7%, 1 week -24.9%, 1 year -92.9%.

bioAffinity Technologies, Inc. (BIAF) is a biotechnology company focused on developing and commercializing advanced in vitro diagnostic platforms for oncology. They specialize in non-invasive diagnostics for early-stage lung cancer and other lung diseases. The company operates through two segments: Diagnostic Research and Development, and Laboratory Services.

Groups BIAF belongs to

• Healthcare
• Biotechnology
• Recent Reverse Splits
• Oncology
• Early Cancer Detection
• Health Diagnostics and Imaging
• Life Sciences
• Medical Devices
• Commercial Stage Biotech
• Healthcare Technology

BIAF financial model: income statement, cash flow and balance sheet